Unknown PHASE2 INTERVENTIONAL 1-arm NCT01409876

HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy

HistoScanning- Based Dose-painting Image-guided Interstitial PDR-brachytherapy in Prostate Cancer - a Phase II Trial

Sponsor: University Hospital Erlangen

Updated 4 times since 2017 Last updated: Aug 3, 2011 Started: Sep 30, 2011 Primary completion: Sep 30, 2014 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01409876, this PHASE2 trial focuses on Prostate Cancer and remains ongoing. Sponsored by University Hospital Erlangen, it has been updated 4 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Erlangen

Data source: University Hospital Erlangen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Erlangen, Germany